NCT06775340View on ClinicalTrials.gov

Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis

PHASE2RecruitingINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

December 31, 2027

Conditions
Adolescent Asthma
Interventions
DRUG

RSS0343 Tabella

RSS0343 tablets, oral;

Trial Locations (1)

510140

RECRUITING

First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY